June 6, 2019 / 7:37 AM / 14 days ago

BRIEF-Bavarian Nordic REPORTS Positive Result From Phase 2 Trial Evaluating BN-Brachyury In Chordoma

June 6(Reuters) - Bavarian Nordic A/S:

* REPORTED ON WEDNESDAY POSITIVE RESULT FROM ONGOING PHASE 2 TRIAL EVALUATING BN-BRACHYURY IN CHORDOMA

* DATA AND SAFETY MONITORING BOARD (DSMB) CONFIRMED PARTIAL RESPONSE IN ONE OF FIRST CHORDOMA PATIENTS RECRUITED AND TREATED WITH COMBINATION OF BN-BRACHYURY AND RADIATION TREATMENT AT FIRST EVALUATION TIMEPOINT

* RECRUITMENT WILL BE EXPANDED TO ENROLL ANOTHER 19 PATIENTS, WHILE THE FIRST 10 PATIENTS CONTINUE TO BE TREATED AND EVALUATED

Source text for Eikon:

Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below